Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A1MMCC8
Mon, 01.08.2022
Medios AG
Press release
Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
Berlin, August 01, 2022 – The Supervisory Board of Medios AG ("Medios") and the Chief Executive Officer (CEO) Matthias Gaertner have agreed to extend the existing Executive Board contract prematurely until January 31, 2025. Matthias Gaertner has been a member of [ … ]
Tue, 21.06.2022
Medios AG
Press ReleaseMedios AG successfully holds Annual General Meeting 2022
Modernization of the Company's Articles of Association approved
Compensation report approved
New Stock Option Plan 2022 adopted
Berlin, June 21, 2022 – Medios AG (“Medios”), the leading provider of Specialty Pharma Solutions in Germany, today successfully held its 2022 Annual [ … ]
Wed, 11.05.2022
Medios AG
Press ReleaseMedios AG: Revenue and earnings at record levels in the first quarter
Double-digit revenue growth and disproportionately high EBITDA pre1 increase
Acquisition of NewCo Pharma Group: Significant strengthening of market position in manufacturing
Outlook 2022 confirmed: Significant and sustainable increase in revenue and earnings expec [ … ]
Tue, 29.03.2022
Medios AG
Press ReleaseMedios AG: Record year 2021 and positive outlook for 2022
Significant increase in revenue and earnings in the 2021 financial year
Still significant growth expected for the 2022 financial year
Berlin, March 29, 2022 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, today published its Annual Report [ … ]
Thu, 03.03.2022
Medios AG
Press ReleaseMedios AG: Revenue expectation for 2021 exceeded - Significant growth planned for 2022
Preliminary consolidated revenue of well over €1.3 billion better than expected
EBITDA pre1 in line and EBT pre1 above forecast
Forecast 2022: Revenue growth in the range of 6.8% - 17.9% and increase in EBITDA pre1 in the range of 35.3% - 50.9%
Be [ … ]
Fri, 11.02.2022
Medios AG
Press ReleaseMedios AG: Bryan, Garnier & Co initiates coverage of Medios with "Buy" recommendation and price target of €65.00
Berlin, February 11, 2022 - Bryan, Garnier & Co today initiated coverage of Medios AG and issued a "Buy" recommendation on the shares of the leading provider of Specialty Pharma solutions in Germany. Accordingly, th [ … ]
Tue, 11.01.2022
Medios AG
Press ReleaseMedios AG: Successful completion of the acquisition of the NewCo Pharma Group - Significant expansion of the market position in the area of manufacturing
Berlin, January 11, 2022 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has successfully completed the acquisition of the specialized pharmace [ … ]
Thu, 16.12.2021
Medios AG
Press ReleaseMedios AG adopts sustainability strategy and plans climate neutrality by 2023
Berlin, December 16, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, published its sustainability strategy today. It contains a comprehensive sustainability program to be implemented by 2025. Progress is measured r [ … ]
Tue, 14.12.2021
Medios AG
Press Release
Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office
Berlin, December 14, 2021 - The German Federal Cartel Office has approved Medios AG's intended takeover of the specialized pharmaceutical manufacturers of the NewCo Pharma Group, Mannheim, on December 14, 2021.
Medios AG had entered into a purchase agreemen [ … ]
Thu, 25.11.2021
Medios AG
Press ReleaseMedios significantly expands its market position in manufacturing with the acquisition of NewCo Pharma Group and taps new growth potentials
Significant strengthening of the segment of patient-specific therapies
Expansion of the network for the nationwide supply of specialized pharmacies
Berlin, November 25, 2021 - Medios AG ("Medios [ … ]